- Home
- KNTK vs OGN Comparison
KNTK vs OGN Comparison
Compare KNTK & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNTK
- OGN
- Stock Information
- Founded
- KNTK 2017
- OGN 1923
- Country
- KNTK United States
- OGN United States
- Employees
- KNTK N/A
- OGN N/A
- Industry
- KNTK Natural Gas Distribution
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- KNTK Utilities
- OGN Health Care
- Exchange
- KNTK Nasdaq
- OGN Nasdaq
- Market Cap
- KNTK 3.8B
- OGN 4.0B
- IPO Year
- KNTK N/A
- OGN N/A
- Fundamental
- Price
- KNTK $65.12
- OGN $15.75
- Analyst Decision
- KNTK Buy
- OGN Hold
- Analyst Count
- KNTK 9
- OGN 3
- Target Price
- KNTK $75.33
- OGN $21.33
- AVG Volume (30 Days)
- KNTK 575.6K
- OGN 4.3M
- Earning Date
- KNTK 02-26-2025
- OGN 02-13-2025
- Dividend Yield
- KNTK 4.79%
- OGN 7.12%
- EPS Growth
- KNTK 221.62
- OGN 120.97
- EPS
- KNTK 2.62
- OGN 5.04
- Revenue
- KNTK $1,446,081,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- KNTK $6.41
- OGN $3.29
- Revenue Next Year
- KNTK $35.15
- OGN $1.93
- P/E Ratio
- KNTK $24.86
- OGN $3.12
- Revenue Growth
- KNTK 20.20
- OGN 4.21
- 52 Week Low
- KNTK $31.73
- OGN $13.87
- 52 Week High
- KNTK $65.38
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- KNTK 74.96
- OGN 53.95
- Support Level
- KNTK $62.01
- OGN $15.52
- Resistance Level
- KNTK $60.41
- OGN $16.10
- Average True Range (ATR)
- KNTK 1.51
- OGN 0.51
- MACD
- KNTK 0.67
- OGN 0.11
- Stochastic Oscillator
- KNTK 97.34
- OGN 71.08
About KNTK Kinetik Holdings Inc.
Kinetik is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. It operates exclusively in Texas, serving the Permian Basin and connecting fields with market hubs and other large pipelines. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines that transport molecules to the Gulf Coast enabling it to obtain exposure to export markets and international demand.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.